NR 565 - advanced pharmacology midterm - Chamberlain Practice EXAM; MOCK practice
NR 565 - advanced pharmacology midterm - Chamberlain Practice EXAM; MOCK practice What are two functions of naloxone when a patient is on buprenorphine? A. Prevention of toxicity B. Stop constipation caused by Buprenorphine C. Cannot readily reverse toxicity already occurring D. Both A and C - Correct Answer D. Both A and C Why must an NP be cautious when prescribing medications to the elderly population? A. Due to their diagnosis of dementia. B. They are high risk for polypharmacy. C. The elderly population metabolizes medication faster. D. Prescribe as usual. No difference in elderly patients. - Correct Answer B. They are high risk for polypharmacy. There are several points of education that should be given to a patient taking acetaminophen. Which of these statements if made by the patient taking acetaminophen is incorrect? A. "If I take one dose, I should wait at least four hours to take another." B. "There is no limit to how many tablets I can take each day." C. "I should not take Tylenol if I have liver disease or chronically drink alcohol." D. "I can take 325-650mg for mild pain, and 500-1000mg for moderate pain." - Correct Answer B. "There is no limit to how many tablets you can take each day." What is the point of a prescription drug monitoring program (PDMP)? A. Help identify patients who may be at risk for overdose B. Make prescribing faster for providers C. Educate patients about overdose D. Provide correct dosing and pricing information for providers - Correct A
Geschreven voor
- Instelling
- NR 565 - advanced pharmacology
- Vak
- NR 565 - advanced pharmacology
Documentinformatie
- Geüpload op
- 29 juli 2025
- Aantal pagina's
- 17
- Geschreven in
- 2024/2025
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
-
what are two functions of naloxone when a patient
-
why must an np be cautious when prescribing medica
-
there are several points of education that should
-
what is the point of a prescription drug monitori